We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-10.95%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.5B
AUM Growth
-$293M
Cap. Flow
-$295M
Cap. Flow %
-11.83%
Top 10 Hldgs %
36.69%
Holding
119
New
16
Increased
26
Reduced
20
Closed
21

Top Buys

Rank Stock Value
1
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$120M
2
VTRS icon
Viatris
VTRS
+$32.1M
3
VCEL icon
Vericel Corp
VCEL
+$31.5M
4
AGN
Allergan plc
AGN
+$29.5M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$28.9M

Top Sells

Rank Stock Value
1
DBVT
DBV Technologies
DBVT
+$65.1M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$62.4M
3
ACHC icon
Acadia Healthcare
ACHC
+$27.8M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$26.9M
5
RGNX icon
Regenxbio
RGNX
+$20.8M

Sector Composition

Rank Sector Weight
1 Healthcare 69.79%
2 Financials 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLGT
101
DELISTED
Teligent, Inc
TLGT
– –
-70,887
Closed -$2.8M
OXFD
102
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-1,087,359
Closed -$17.6M
EIDX
103
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-420,409
Closed -$4.2M
AIMT
104
DELISTED
Aimmune Therapeutics
AIMT
– –
-553,000
Closed -$15.1M
FOMX
105
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-234,745
Closed -$1.34M
NITE
106
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-499,747
Closed -$10.2M
ECYT
107
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-3,514,084
Closed -$62.4M
PTX
108
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-658,826
Closed -$635K
BHVN
109
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-239,000
Closed -$8.97M
1 2 3 4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2018 Portfolio in Review

As of Q4 2018, Deerfield Management held 119 positions worth $2.5B, down 11% from $2.79B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Deerfield Management withdrew a net $295M in Q4 2018, closing 21 positions and reducing 20 holdings. Its most notable exit was DBV Technologies, an estimated $65.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 69% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Orchard Therapeutics plc American Depositary Shares worth $126M.

  • Deerfield Management's largest Q4 2018 buy was Orchard Therapeutics plc American Depositary Shares: 802,360 shares worth $126M.
  • Deerfield Management added most to Viatris in Q4 2018, an estimated $32.1M increase.
  • Deerfield Management's biggest Q4 2018 reduction was Acadia Healthcare, cutting an estimated $27.8M.
  • Deerfield Management fully exited DBV Technologies in Q4 2018, selling an estimated $65.1M.
  • Deerfield Management's ten largest holdings make up 37% of its $2.5B portfolio in Q4 2018.
  • Deerfield Management opened 16 new positions and closed 21 in Q4 2018.
  • Deerfield Management's portfolio value fell 11% quarter-over-quarter to $2.5B.

Based on Deerfield Management's 13F filing for Q4 2018, filed 14 Feb 2019.